In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 14 May 2019. Sen. Patty Murray.

Executive Summary

US Sen. Patty Murray, the ranking member of the Senate Health, Education, Labor and Pensions (HELP) Committee, has demanded answers from three duodenoscope-makers on whether closed-channel duodenoscopes remain safe, given recent findings of high contamination rates by the FDA. See what she wrote here.

“While important steps have been taken to reduce outbreaks, it is unacceptable that one in 20 patients who undergo a procedure using a duodenoscope may acquire an infection as a result of [medical] procedures – even when hospitals have followed cleaning instructions properly.” – Patty Murray, US senator, D-WA

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125095

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel